<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Damaschke NA</submitter><funding>NCI NIH HHS</funding><pagination>5236-5247</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9741865</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>77(19)</volume><pubmed_abstract>Loss of imprinting (LOI) is an epigenetic event that relaxes an allele-specific restriction on gene expression. One gene that experiences LOI is the paracrine insulin-like growth factor &lt;i>IGF2&lt;/i>, which occurs commonly in human prostate tissues during aging and tumorigenesis. However, the relationship between &lt;i>IGF2&lt;/i> LOI and prostate tumorigenesis has not been established functionally. In this study, we created a mouse model with CTCF-binding site mutations at the &lt;i>Igf2-H19&lt;/i> imprint control region that abolishes CTCF insulator activity, resulting in biallelic &lt;i>Igf2&lt;/i> expression that mimics increased levels seen with aging-induced LOI. We found that &lt;i>Igf2&lt;/i> LOI increased the prevalence and severity of prostatic intraepithelial neoplasia (PIN), a premalignant lesion. Engin</pubmed_abstract><journal>Cancer research</journal><pubmed_title>Loss of &lt;i>Igf2&lt;/i> Gene Imprinting in Murine Prostate Promotes Widespread Neoplastic Growth.</pubmed_title><pmcid>PMC9741865</pmcid><funding_grant_id>R01 CA097131</funding_grant_id><pubmed_authors>Blute ML</pubmed_authors><pubmed_authors>Bhusari S</pubmed_authors><pubmed_authors>Huang W</pubmed_authors><pubmed_authors>Damaschke NA</pubmed_authors><pubmed_authors>Avilla M</pubmed_authors><pubmed_authors>Zhong W</pubmed_authors><pubmed_authors>Jarrard DF</pubmed_authors><pubmed_authors>Yang B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Loss of &lt;i>Igf2&lt;/i> Gene Imprinting in Murine Prostate Promotes Widespread Neoplastic Growth.</name><description>Loss of imprinting (LOI) is an epigenetic event that relaxes an allele-specific restriction on gene expression. One gene that experiences LOI is the paracrine insulin-like growth factor &lt;i>IGF2&lt;/i>, which occurs commonly in human prostate tissues during aging and tumorigenesis. However, the relationship between &lt;i>IGF2&lt;/i> LOI and prostate tumorigenesis has not been established functionally. In this study, we created a mouse model with CTCF-binding site mutations at the &lt;i>Igf2-H19&lt;/i> imprint control region that abolishes CTCF insulator activity, resulting in biallelic &lt;i>Igf2&lt;/i> expression that mimics increased levels seen with aging-induced LOI. We found that &lt;i>Igf2&lt;/i> LOI increased the prevalence and severity of prostatic intraepithelial neoplasia (PIN), a premalignant lesion. Engin</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Oct</publication><modification>2025-04-26T02:10:26.108Z</modification><creation>2025-04-06T10:24:05.273Z</creation></dates><accession>S-EPMC9741865</accession><cross_references><pubmed>28775169</pubmed><doi>10.1158/0008-5472.can-16-3089</doi><doi>10.1158/0008-5472.CAN-16-3089</doi></cross_references></HashMap>